8-K filing — CalciMedica, Inc. (CALC)
Filed: 2026-09-02 AccNo: 0001193125-26-379419 Size: 140 KB Item 8.01: Other Events
Filings · News reference
CalciMedica Files Prospectus For Resale Of Up To 56,020,287 Shares
https://www.sec.gov/Archives/edgar/data/1534133/000119312526316100/d169379ds3.htm
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
CalciMedica shares are trading lower after the company announced a 1-for-5 reverse stock split.
CalciMedica Announces 1-For-5 Reverse Stock Split, Effective August 28
CalciMedica Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for
Guggenheim Initiates Coverage On CalciMedica with Buy Rating, Announces Price Target of $9
Guggenheim analyst Vamil Divan initiates coverage on CalciMedica (NASDAQ:CALC) with a Buy rating and announces Price Target of $9.